Blog Posts
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC
faculty.mdanderson.org

High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy – JITC

Journal for ImmunoTherapy of Cancer shared a post on X:

“New JITC article: High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC.”

High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

Authors: Mehmet Altan et al.

T cell diversity

cancer Journal for ImmunoTherapy of Cancer (JITC) Mehmet Altan NSCLC OncoDaily Oncology